Skip to main content

Dixon Translational Research Grants

The Dixon Translational Research Grants Initiative is seeking proposals for innovative, multi-disciplinary clinical and translational research collaborations at Northwestern Medicine that can make an impact in medical science at a national level.

The Northwestern University Clinical and Translational Sciences (NUCATS) Institute and Northwestern Memorial Foundation (NMF) have formally announced a Request for Applications for the 2022 Dixon Translational Research Grants Initiative.

The application submission deadline is Friday, March 18, 2022, by 5 p.m. CT. 

Three Award Classifications

Innovation Award

Supports research opportunities with the potential to advance Northwestern Medicine strategies.

New Investigator Award

Stimulates development of extramural funding for fellows, residents, or clinical investigators within the first three years of their career.

Priority Research Initiative (PRI) proposals

Supports significant, multidisciplinary research with the capability to produce innovative outcomes in a strategic priority clinical area.

Funding Levels:

  • Innovation Award: $50,000 maximum, for two years.
  • New Investigator Award: $35,000 maximum, for two years.
  • Priority Research Initiative: $300,000 maximum, for three years.

Eligibility Requirements

This opportunity is open to all physicians, nurses, and allied healthcare professionals. Priority is given to new investigators and novel projects that enhance clinical and translational research at Northwestern Memorial Hospital and facilitate research that can make a meaningful impact on medical science at a national level. Project applicants must provide an NMHC fund account, and projects must have IRB approval.

For application questions, contact Keith Herzog.

For questions regarding NITRO Competitions, email

Individuals planning to use NUCATS clinical trial support services are required to contact Toddie Hays for budget preparation and planning assistance.

Participating Institutions: